4.8 Article

Uric acid transport and disease

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 120, Issue 6, Pages 1791-1799

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI42344

Keywords

-

Funding

  1. Swiss National Science Foundation [31003A-113525]
  2. European Union

Ask authors/readers for more resources

Uric acid is the metabolic end product of purine metabolism in humans. It has antioxidant properties that may be protective but can also be pro-oxidant, depending on its chemical microenvironrnent. Hyperuricemia predisposes to disease through the formation of urate crystals that cause gout, but hyperuricemia, independent of crystal formation, has also been linked with hypertension, atherosclerosis, insulin resistance, and diabetes. We discuss here the biology of urate metabolism and its role in disease. We also cover the genetics of urate transport, including URAT1, and recent studies identifying SLC2A9, which encodes the glucose transporter family isoform Glut9, as a major determinant of plasma uric acid levels and of gout development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available